BCAL Diagnostics Ltd News

BCAL Diagnostics Appoints CEO

Breast cancer screening and diagnostic company BCAL Diagnostics (ASX:BDX) named Shane Ryan as chief executive officer, effective April 2, to drive the company's commercialization strategy and launch i

MT NewswiresMar 6 07:28

BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India

BCAL Diagnostics (ASX:BDX) joined forces with the Krishna Institute of Medical Sciences and the Basavatarakam Indo-American Hospital to conduct a pilot study for the use of the diagnostic firm's blood

MT NewswiresNov 29, 2023 14:57

BCAL Diagnostics Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Fall 5%

BCAL Diagnostics (ASX:BDX) secured a AU$3 million rebate for the fiscal year ended June 30 from the Australian government's research and development scheme, the diagnostic firm said on Tuesday. The sc

MT NewswiresNov 14, 2023 11:02

BCAL Diagnostics Files for Additional Australian Patent Application

BCAL Diagnostics (ASX:BDX) filed for further provisional patent application in Australia. The application covered additional lipid biomarkers detected in the screening company's breast cancer diagnost

MT NewswiresNov 6, 2023 14:48

Blood Screening Market Size to Grow by USD 1.17 Billion From 2022-2027| Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., and More Among the Major Companies in the Market - Technavio

The Blood Screening Market size is expected to grow by USD 1.17 billion, accelerating at a CAGR of 7.42% during the forecast period, according to...

PR NewswireNov 3, 2023 07:45

BCAL Diagnostics Appoints COO

BCAL Diagnostics (ASX:BDX) appointed Shane Ryan as chief operating officer, effective Sept. 21. Ryan was recently the global senior vice president strategy and innovation-patient access for GenesisCar

MT NewswiresSep 5, 2023 09:34

ASX Closes 1.29% Lower as US Sovereign Rating Falls

At the end of the trading day, the S&P/ASX 200 experienced a decline of 1.29 per cent, closing at 7,354.70. This drop was attributed to market nerves exacerbated by the downgrading of the US sovereign

sharecafeAug 2, 2023 14:43

ASX Down 0.7% at Noon: UBS Analysts Forecast Upside for Health Insurers

According to UBS analysts, Suncorp (ASX:SUN), Hub24 (ASX:HUB), GQG Partners, and Magellan (ASX:MFG) are potential sources of upside in the upcoming reporting season. They believe that Medibank (ASX:MP

sharecafeAug 2, 2023 10:23

Stocks of the Hour: Tamboran Res, Sayona Mining, BCAL Diagnostics, Nova Eye Medical

Tamboran Resources (ASX:TBN) has signed four separate non-binding Letters of Intent with Origin, AGL, EnergyAustralia and Shell Energy Australia to potentially purchase gas from Tamboran's low-reservo

sharecafeAug 2, 2023 09:50